Chronological development of elevated aminotransferases in a nonalcoholic population
- PMID: 15690483
- DOI: 10.1002/hep.20543
Chronological development of elevated aminotransferases in a nonalcoholic population
Abstract
The incidence and risk factors of nonalcoholic fatty liver disease (NAFLD) have never been prospectively determined. To determine the frequency and risk factors of NAFLD and chronological ordering between NAFLD, weight gain, and features of insulin resistance, a historical cohort study was conducted in a Japanese workplace. A cohort free of previous liver injury, alcohol consumption of more than 140 g/wk, and hepatitis B or C infection (529 of 1537 subjects), and a subcohort of 287 subjects free of insulin resistance-related features were identified. Elevated aminotransferases in nonalcoholics were used as a surrogate for NAFLD. High aminotransferases together with weight gain of more than 2 kg and insulin resistance-related features in the subcohort were sought for up to 5 years. The incidence of high aminotransferases was 31 per 1000 person-years (71 events). A significant interaction occurred between age and sex in the development of high aminotransferases. In subjects younger than age 40 years, male sex (hazard ratio [HR]: 4.6), elevated body mass index (HR: 2.1), hypertension (HR: 2.6), and low high-density lipoprotein cholesterol (HR: 2.8) increased the risk of high aminotransferases, whereas age (HR: 0.6 for each 5 years) decreased the risk. In subjects older than age 40 years, glucose intolerance (HR: 5.3) was the only significant risk factor. In the subcohort, weight gain preceded high aminotransferases and other insulin resistance-related features, which appeared sequentially in order of low high-density lipoprotein cholesterol, hypertriglyceridemia/hypertransaminasemia/hypertension, and glucose intolerance. In conclusion, this cohort study clearly showed chronological ordering and an association between development of elevated aminotransferases and risk factors of NAFLD.
Similar articles
-
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.Clin Infect Dis. 2008 Jul 15;47(2):250-7. doi: 10.1086/589294. Clin Infect Dis. 2008. PMID: 18532884
-
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.Hepatology. 2006 Dec;44(6):1648-55. doi: 10.1002/hep.21429. Hepatology. 2006. PMID: 17133473
-
NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.Hepatology. 2006 Aug;44(2):458-65. doi: 10.1002/hep.21262. Hepatology. 2006. PMID: 16871574
-
Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.Arch Intern Med. 2004 Oct 25;164(19):2169-75. doi: 10.1001/archinte.164.19.2169. Arch Intern Med. 2004. PMID: 15505132
-
The epidemiology of nonalcoholic fatty liver disease in adults.J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S5-10. doi: 10.1097/01.mcg.0000168638.84840.ff. J Clin Gastroenterol. 2006. PMID: 16540768 Review.
Cited by
-
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.Ann N Y Acad Sci. 2013 Apr;1281(1):106-22. doi: 10.1111/nyas.12016. Epub 2013 Jan 30. Ann N Y Acad Sci. 2013. PMID: 23363012 Free PMC article. Review.
-
Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature.J Gastroenterol. 2006 Aug;41(8):725-32. doi: 10.1007/s00535-006-1876-0. J Gastroenterol. 2006. PMID: 16988759 Review.
-
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.J Clin Transl Hepatol. 2021 Dec 28;9(6):972-982. doi: 10.14218/JCTH.2021.00201. Epub 2021 Aug 30. J Clin Transl Hepatol. 2021. PMID: 34966660 Free PMC article. Review.
-
NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS USING TRANSIENT ELASTOGRAPHY AND CONTROLLED ATTENUATION PARAMETER IN TYPE 2 DIABETES PATIENTS.Acta Endocrinol (Buchar). 2018 Jul-Sep;14(3):394-400. doi: 10.4183/aeb.2018.394. Acta Endocrinol (Buchar). 2018. PMID: 31149289 Free PMC article.
-
Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China.Medicine (Baltimore). 2018 Mar;97(9):e0021. doi: 10.1097/MD.0000000000010021. Medicine (Baltimore). 2018. PMID: 29489647 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical